One possible explanation why LPS is much more potent and faster than other agonists to promote MIP-1β synthesis and release could be due to the fact that LPS is a bacterial membrane component, and it is essential that neutrophils react rapidly and strongly to this pathological inflammatory mediator to stop any infection. This evidence concerns the gene CCL4 and infection.